Search Results - "Molderings, G"

Refine Results
  1. 1
  2. 2

    Serotonin and beyond—a tribute to Manfred Göthert (1939-2019) by Bönisch, H., Fink, K. B., Malinowska, B., Molderings, G. J., Schlicker, E.

    “…Manfred Göthert, who had served Naunyn-Schmiedeberg’s Arch Pharmacol as Managing Editor from 1998 to 2005, deceased in June 2019. His scientific oeuvre…”
    Get full text
    Journal Article
  3. 3

    Cystic diseases in urology : Recommendations for patients with systemic mast cell disease by Knüpfer, H E, Keppler, V, Zienkiewicz, T, Molderings, G J

    Published in Urologe. Ausgabe A (01-10-2022)
    “…The systemic mast cell disease (MCAD; prevalence 17%) may occur frequently in urological patients. MCAD-induced changes include cysts in all organs, also in…”
    Get full text
    Journal Article
  4. 4

    Direct inhibition by cannabinoids of human 5‐HT3A receptors: probable involvement of an allosteric modulatory site by Barann, M, Molderings, G, Brüss, M, Bönisch, H, Urban, B W, Göthert, M

    Published in British journal of pharmacology (01-11-2002)
    “…Excised outside‐out patches from HEK293 cells stably transfected with the human (h) 5‐HT3A receptor cDNA were used to determine the effects of cannabinoid…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The transcriptome of the human mast cell leukemia cells HMC-1.2: an approach to identify specific changes in the gene expression profile in KitD816V systemic mastocytosis by Haenisch, B., Herms, S., Molderings, G. J.

    Published in Immunologic research (01-05-2013)
    “…To circumvent the costly isolation procedure associated with tissue mast cells, human mast cell lines such as HMC-1 are employed in mastocytosis research, but…”
    Get full text
    Journal Article
  7. 7

    Molecular basis for the antiproliferative effect of agmatine in tumor cells of colonic, hepatic, and neuronal origin by Wolf, C, Brüss, M, Hänisch, B, Göthert, M, von Kügelgen, I, Molderings, G J

    Published in Molecular pharmacology (01-01-2007)
    “…The aim of the present study was to challenge potential mechanisms of action underlying the inhibition of tumor cell proliferation by agmatine. Agmatine…”
    Get more information
    Journal Article
  8. 8

    Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome by Frieling, T, Meis, K, Kolck, U W, Homann, J, Hülsdonk, A, Haars, U, Hertfelder, H-J, Oldenburg, J, Seidel, H, Molderings, G J

    Published in Zeitschrift fur Gastroenterologie (01-02-2011)
    “…Previous findings suggested an involvement of mast cells in the pathogenesis of irritable bowel syndrome (IBS). The pathophysiological significance of mast…”
    Get more information
    Journal Article
  9. 9

    N-type calcium channels control sympathetic neurotransmission in human heart atrium by MOLDERINGS, G. J, LIKUNGU, J, GÖTHERT, M

    Published in Circulation (New York, N.Y.) (01-02-2000)
    “…Because knowledge about the type of calcium channels involved in action potential-induced norepinephrine release from the human peripheral sympathetic nervous…”
    Get full text
    Journal Article
  10. 10

    The measurement of leukotrienes in urine as diagnostic option in systemic mastocytosis by Raithel, M, Zopf, Y, Kimpel, S, Naegel, A, Molderings, G J, Buchwald, F, Schultis, H W, Kressel, J, Hahn, E G, Konturek, P

    “…Clinical symptoms of patients with mastocytosis may include skin reactions, but also gastrointestinal symptoms with hyperacidity and dysmotility (e.g. ulcer,…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis by Heller, Jörg, Schepke, Michael, Gehnen, Nina, Molderings ‡, Gerhard J., Müller §, Andreas, Erhard ∥, Jochen, Spengler, Ulrich, Sauerbruch, Tilman

    Published in Gastroenterology (New York, N.Y. 1943) (01-02-1999)
    “…Background & Aims: Patients with cirrhosis are characterized by a reduced splanchnic vascular resistance and a hyporeactivity to adrenergic vasoconstrictors…”
    Get full text
    Journal Article
  13. 13

    Presynaptic imidazoline receptors and non‐adrenoceptor[3H]‐idazoxan binding sites in human cardiovascular tissues by Molderings, G. J., Likungu, J., Jakschik, J., Göthert, M.

    Published in British journal of pharmacology (01-09-1997)
    “…1 In segments of human right atrial appendages and pulmonary arteries preincubated with [3H]‐noradrenaline and superfused with physiological salt solution…”
    Get full text
    Journal Article
  14. 14

    Pharmacological characteristics of the specific transporter for the endogenous cell growth inhibitor agmatine in six tumor cell lines by HEINEN, A, BRÜSS, M, BÖNISCH, H, GÖTHERT, M, MOLDERINGS, G. J

    “…This study examined agmatine transport into six human intestinal tumor cell lines and compared the pharmacological properties of this transporter with those of…”
    Get full text
    Journal Article
  15. 15

    Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship by Molderings, G J, Likungu, J, Göthert, M

    “…Segments of human right atrial appendages preincubated with [3H]noradrenaline and superfused with physiological salt solution containing desipramine and…”
    Get full text
    Journal Article
  16. 16

    Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activation by Molderings, G J, Menzel, S, Kathmann, M, Schlicker, E, Göthert, M

    Published in British journal of pharmacology (01-08-2000)
    “…In segments of rat vena cava preincubated with [(3)H]-noradrenaline and superfused with physiological salt solution, the influence of agmatine on the…”
    Get full text
    Journal Article
  17. 17

    Agmatine and putrescine uptake in the human glioma cell line SK-MG-1 by Molderings, G J, Bönisch, H, Göthert, M, Brüss, M

    “…The pharmacological properties of a specific agmatine uptake mechanism were investigated in the human glioma cell line SK-MG-1 and compared with those of the…”
    Get full text
    Journal Article
  18. 18

    Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors by Schlicker, E, Fink, K, Molderings, G J, Price, G W, Duckworth, M, Gaster, L, Middlemiss, D N, Zentner, J, Likungu, J, Göthert, M

    “…Human cerebral cortical slices and synaptosomes, guinea-pig cerebral cortical slices and human right atrial appendages were used to study the effects of…”
    Get full text
    Journal Article
  19. 19

    Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors by Cubeddu, L X, Bönisch, H, Göthert, M, Molderings, G, Racké, K, Ramadori, G, Miller, K J, Schwörer, H

    “…Nearly 30% of patients treated with metformin experience gastrointestinal side effects. Since release of 5-hydroxytryptamine (5-HT) from the intestine is…”
    Get full text
    Journal Article
  20. 20

    Presynaptic Imidazoline Receptors: New Developments in Characterization and Classification by GÖTHERT, M., BRÜSS, M., BÖNISCH, H., MOLDERINGS, G. J.

    Published in Annals of the New York Academy of Sciences (21-06-1999)
    “…Presynaptic imidazoline receptors (IRs) which inhibit norepinephrine (NE) release from sympathetic nerve endings have been identified in cardiovascular tissue…”
    Get full text
    Journal Article